Bloody cerebrospinal fluid is thought to increase the risk of arachnoiditis from myelography with iophendylate, but not with aqueous media. An experimental study was undertaken of the effects of metrizamide, iocarmate, and blood , independently and in mixtures, on the production of arachnoid fibrosis. Monkeys exposed to a mixture of iocarmate or metrizamide and blood developed no more significant arachnoid fibrosis than animals exposed to the contrast medium alone. Lumbar puncture with bloody cerebrospinal fluid, although a possible cause of adverse effects, is not a contraindication to proceeding with metrizamide myelography.
Bloody cerebrospinal fluid is not considered a contraindication to metrizamid e myelography by radiologists [1] , but is listed as a warning by the manufacturer in the package insert. To date, no c lini cal observations and only a few expe rimental data have been reported [2] on the effect of bloody ce rebrosp in al fluid on compli cations from metrizamide mye lography , although a synergi stic effect of intrathecal blood and oil y contrast media has been demonstrated previously [3, 4] . Therefore , we studied the effect of small amounts of blood in the ce rebrosp in al fluid on arachnoiditis from meglumine iocarmate or metrizamid e myelography.
Materials and Methods
Thirty bonn et, macaque , or nemestrin a monkeys we ighin g 5-7 kg we re used for these stud ies. All animals had successfully passed a 40 day quaran tin e and myco bac teri al and intestin al parasite testing . For th e in trathecal injecti ons or mye log raphy, each animal was fasted overnight and premedicated with atropin e and phencyc li din e hyd roc hloride. After its back was shaved and prepared in routin e manner , th e anim al was pl aced prone on a myelograph ic table ti lted 15° head-end up. Th e subarac hn oid space was pun c tured at th e L3-4 interspace with a disposable 22 gauge need le, and th e co ntrast medium and / or b lood was injected into th e subarachnoid space. Th e substances injec ted are li sted in table 1. Autologous bl ood was ob tain ed by a ve nipuncture immediately before th e injecti on. Wh en blood and co ntrast mediu m we re injected , th ey we re mi xed togethe r in th e sa me sy~ing e before injection. Radiograph s were ob tain ed at 1 min after intratheca l iniecti on to co nfirm th at the contrast med ium was subara c hnoid . After th e injec ti on, th e animal was placed in sitting position in a prim ate restraint c hair overnight. Th e animals were sac rifi ced 12 week s later, and the lumbar sac was removed , fi xed, stai ned, and embedded in routine manner. Transverse hi stologi c sec ti ons at L5, L6 , and L 7 we re examined by lig ht mi crosco py and sc ored for severity of arachnoiditis accord in g to th e following grad in g system: At each of three levels, th e arachnoid membrane was scored on a scale of 0-4. For no abnorm alit y, 0 scored; for a question abl e thi c kening, 1 was scored; for a sli ghtl y abnorm al amount of co ll agen in th e arachnoid , 2; for moderate fi brosis, 3; and for severe thi cke ning , 4. Infiltration of th e adjacent subarachnoid and subdural space wi th fibroblasts and co ll agen was similarl y scored 0-4 . Thu s, th e minimal and max im al myelographic scores were 0 and 36, respective ly. 
Results
No .
Animals Arachnoiditis Scores
Range Average Th e animal s tolerated myelography without seizures or oth er ac ute se ri ous reactions . Th e resu lts of the grading for arac hnoiditi s are shown in table 1.
The four animal s in group 1 receiving 2.4 ml of metrizamide alone (300 mg I/ ml) had very mild arachnoid thickening on histologi c examinatio n. Th e scores were 9-11. The four animals rece iving 2.4 ml of a mixture of blood and metri zamid e with a resulting conce ntration of 300 mg Il ml also showed v e ry mild thickening of the arachnoid. The sco res were 6-12 (averag e, 7.8). The difference between group 1 and group 2 animal s was not statistically significant (Wil coxan Rank Sum Test).
All eight animals in group 3 that received 1 .2 ml of iocarmate alone had evidence of mil d, moderate, or severe arac hnoid fibro sis. The scores were 10-27 (averag e, 19.3).
Five animals rece iving 0.7 ml of iocarmate (group 4) had essentially no evid ence of arach noid fibrosis . The scores were 2-6 (average, 3.4).
The an imals in group 5 that received iocarm ate (0.7 ml) and blood had evidence of minimal to moderate arac hnoid fibrosis. The scores were 2-19 (average, 7.4). Group 4 and 5 scores were significantly different from group 3 (p < 0 .05, Wil coxan Rank Sum Test) but not from eac h other.
Discussion
The primate mod el for measuring postmyelographic arachnoiditi s has been described and its value in identifying the factors causing postmyelograp hi c arachnoiditis has been demonstrated [2 , 5] .
A possible synergistic effect of blood and aqueous contrast media on the arachno id could be studied by inj ecting the blood eith er before or together with the co ntrast medium into th e subarachnoid space. Although the former may reflect th e c linical situation more accurately , th e possibility th at th e contrast medium could displ ace blood from the caudal sac co ul d not be excluded. Therefore , we selected the latter technique to ensu re that the arachnoid was uniform ly exposed to both contrast medium and blood. The second experim ental choice was to compare a blood-contrast med iu m mi xture with an equal volume or weig ht or concentration of th e co ntrast medium alone. We performed each type of comparison. Since it was distributed as a solution, we used iocarmate in one co ncentration (282 mg I/ ml) , but in different volumes (0.7 or 1.2); since it is distributed as a lyophilized powder, we used metrizamide in different concentrations. We chose to reconstitute it to a conce ntration of 380 mg Il ml (in excess of th e manufacturer's recommendation) so that when mi xe d with blood it had a concentration of 300 mg I/ mi. The 300 mg Il ml concentration produces arachnoiditis in monkeys, if the animals are dehydrated overnight and kept in a sitting position in a primate restraint chair after the myelogram [2] .
In the present study , th e metrizamide-blood mixture containing 300 mg Il ml produced less arachnoiditis than metrizamide alone containing 300 mg I/ mi. In another study, the mi xture of metrizamide (380 mg I/ ml) plus blood produced less arachnoiditis than metrizamide (380 mg I/ ml) alone [6] . Also in a previous study, a metrizamide-blood mixture containing 220 mg Il ml was no more harmful than metrizamide alone containing 220 mg Il ml [2] .
locarmate is no longer marketed in the United States. We used it in these studies because arachnoiditis is more easi ly detected following its intrathecal use. The mixture of iocarmate and blood produced significantly less arachnoiditis than an equal volume of iocarmate alone (group 3) and not significantly more arachnoiditis than an equal weight of iocarmate alone (group 4). These data show that diluting iocarmate with blood decreases its risk of causing arachnoiditis, just as does di luting it with water [7] .
In these studies, blood did not increase the risk of arachnoiditis from aqueous myelographic contrast media. However, blood alone can produce arachnoiditis and acute toxicity [2] . We conclude, therefore, that bloody cerebrospinal fluid, although producing some adverse effects, is not a c ontraindication to aqueous myelography or an indication to postpone aqueous myelography . If blood is found in the cerebrospinal fluid before myelography, aqueous media are preferable to Pantopaque, since experimental evidence suggests Pantopaque and blood are synergistic in produc ing arachnoiditis [3, 4] .
